Ampa

Ampa is a health technology company based in an undisclosed location that develops scalable brain stimulation therapies, specifically transcranial magnetic stimulation, to treat severe mental health conditions that remain unresponsive to conventional psychiatric treatments. The organization integrates advanced neuroscience and artificial intelligence to engineer practical neuromodulation solutions designed to restore mental well-being and provide alternative therapeutic options for complex psychiatric care. Operating within the specialized medical device sector, the enterprise explicitly targets clinical remission for up to one billion patients suffering from various treatment-resistant mental and neurological disorders globally. As an early-stage health tech startup, the firm focuses on advancing its proprietary stimulation technology through necessary clinical approval processes prior to widespread commercialization and deployment in clinical settings. Ampa was established in an undisclosed year by neuroscientist Don Vaughn and healthcare leader Gregory David.